-
Xinda Bio publishes key data from IBI305 clinical studies
Time of Update: 2021-02-09
Cinda Biopharmaceuticals announced today that at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO), IBI305 (Beva Pearl Monobiogenic Similar Drug) was published in the form of a poster (poster) comparing the trial data for the first-line treatment of advanced non-scale non-small cell lung cancer (NCT02954172).
-
AstraZenecon PD-L1 therapy combination reaches phase 3 clinical end
Time of Update: 2021-02-09
Today, AstraZeneca announced that its development of the PD-L1 monoclonal antibody Imfinzi (durvalumab) significantly improved the total survival of patients in Phase 3 clinical trials for the first-line treatment of widespread small cell lung cancer (ES-SCLC), reaching the main end of the trial.
-
The development of noel virus vaccine is one step faster in our country
Time of Update: 2021-02-09
The researchers found that the vaccinated antibodies were polarized and formed by previous norovirus infections, and that GII.4-specific antibodies blocked ancestral strains or antibodies that bind to different genotypes, and did not block the virus from entering the mating body.
-
New technology to see 'brain traffic map'
Time of Update: 2021-02-09
Recently, a team of professors from Zhejiang University School of Medicine's Institute of Systemic Neurology and Cognitive Sciences, Professor Wang Wei, developed infrared neurostatific functional magnetic resonance integration technology, which for the first time obtained sub-millimeter-level brain connection groups in the living brain, so as to achieve a faster, more systematic and clearer view of the "brain traffic map" to understand the transmission trajectory of information.
-
U.S. researchers 3D print out complex veins
Time of Update: 2021-02-09
Jordan Miller, co-author of the paper and an assistant professor of bioengineering at Rice University in the United States, says one of the biggest obstacles to artificial functional tissue is the inability to create complex vein systems that transport nutrients into dense human tissues, such as trachea and blood vessels in the lungs and bile tubes and blood vessels in the liver, each with separate systems, structures and functions.
-
The risk of death from sepsis can last up to five years
Time of Update: 2021-02-09
"This is the first report to use UK national data to confirm the long-term risk of death for sepsis survivors.
We now know the severity of this long-term risk of death among sepsis survivors," explains Dr. Manu Shankar-Hari, a clinician at the National Institutes of Health.
-
Powerful MRI technology can be scanned continuously for up to 100 hours
Time of Update: 2021-02-09
With the support of powerful magnetic resonance imaging (MRI) technology, after more than 100 hours of scanning, U.S. researchers have obtained the most detailed three-dimensional image of the human brain to date, with a resolution large enough to show objects less than 0.1 mm in diameter, promising to improve understanding of health and the structure of the brain, Science News reported.
-
The probability of mutation of ovarian cancer anti-cancer gene is clear
Time of Update: 2021-02-09
May 6, Fudan University Affiliated Cancer Hospital held a presentation of ovarian cancer research results, professor Wu Xiaohua led the ovarian cancer research team for many years, the first multi-center ovarian cancer embryo clinical study found that in China's ovarian cancer patients, the risk of BRCA1 and BRCA2 gene mutation in the body as high as 28.5%.
-
Genetic studies reveal the metabolic origins of anorexia
Time of Update: 2021-02-09
a global study led by researchers at King's College London and the University of North Carolina at Chapel Hill found that anorexia nerve is at least partly a metabolic disorder, rather than what was previously thought to be pure psychosis.
-
The flu Terminator? New study finds 10,000 T-cells! Universal influenza vaccine is out!
Time of Update: 2021-02-09
recently, scientists claimed to have discovered immune cells that can fight all known influenza viruses, in what has been hailed as a major breakthrough that could help develop a universal one-off vaccine against multiple diseases.
-
Mobile phone software accurately diagnoses respiratory diseases
Time of Update: 2021-02-09
According to a recent study published in the open-access journal Respiratory Research, scientists combine machine learning with clinical medicine to enable automated analytics embedded in a smartphone app (APP) to diagnose respiratory diseases with high accuracy, which is not easy for human doctors.
-
New mechanisms for tumors to evade immune attacks have been discovered
Time of Update: 2021-02-09
Professor Zhang Yi and Professor Zhao Jie's team took the tumor immune microenvironment as the starting point, and based on the results of gene sequencing, they found that after the tumor cell metabolic molecule glycogen branch enzyme 1 was knocked down, it was possible to induce the production of type I interferon by interferon activation protein signaling path, thus enhancing the ability of chemokine to recruit T lymphocytes.
-
Reduce cell manufacturing time and increase cell yield! TG Medical completes the important layout of the cell manufacturing process!
Time of Update: 2021-02-09
From the development of automated cell manufacturing technology platforms to the strengthening of the supply chain, Boya's TG Medical continues to contribute to the standardization of large-scale cell manufacturing to meet the growing market demand and ultimately improve access to cell therapy for the benefit of more patients.
-
Temporary scans during prostate cancer treatment can help guide treatment
Time of Update: 2021-02-09
After two rounds of l-177 (177Lu)-PSMA radiological ligand therapy, metastatic degenerative antigen (PSMA) electron emission fault scanning (PET) imaging showed significant predictive value for patient survival.
In Phase 2 clinical trials, 177 Lu-PSMA treatments showed promising results in treating patients with metastatic desopathic prostate cancer.
-
Allergan developed and approved a new muscle enhancer
Time of Update: 2021-02-09
Grant Stevens, the clinic's founder, said of the new product's approval: "By working with Allergan, we can offer our patients new medical solutions for body contours.
-
Gilead worked with ab Cellera's team to fight infectious diseases
Time of Update: 2021-02-09
The two companies said the partnership will focus on the discovery of ultra-rare antibodies of certain properties for the treatment of a range of infectious diseases, with AbCellera applying its expertise in single-cell screening of natural immune sources to produce a wealth of candidate antibodies evaluated by Gilead.
-
Figures in the British Medical Journal suggest there is a link between sugary drinks and cancer
Time of Update: 2021-02-09
the data came from a team of researchers in France who assessed the intake of sugary drinks (sugary drinks and 100% fruit juice), artificially added sugar drinks, and the overall risk of cancer, breast, prostate and bowel cancer.
-
Pfizer announced the preliminary results of gene therapy in Phase 1b clinical trials
Time of Update: 2021-02-09
the results showed that this gene therapy can improve the expression of antimyostrophy protein in the patient's muscles, and improve muscle function indicators.
-
3D bioprinting models transform cancer drug development and tumor therapy
Time of Update: 2021-02-09
In the study, recently published in Advanced Materials, Dr. Angela Panoskaltsis-Mortari, associate director of research at the University of Minnesota School of Medicine, professor of pediatrics, director of the 3D Bioprinting Equipment Department and a member of the Masonic Cancer Center, and her assistant researchers found that cells behave differently in these 3D flexible tissue environments than on 2D plastic or glass surfaces.
-
A new small molecule screening platform is beginning to show up to accelerate the development of cancer immunotherapy
Time of Update: 2021-02-09
researchers believe the test could continue to expand, using a variety of different immune cells to screen for compounds that activate the immune response, as well as testing the reverse effects of small molecular compounds on other cancer-causing mutations.
